Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fusion Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
FUSN
Nasdaq
8731
https://fusionpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fusion Pharmaceuticals Inc
Pharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
- Mar 22nd, 2024 3:59 pm
Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates
- Mar 20th, 2024 8:05 pm
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
- Mar 20th, 2024 5:21 pm
AstraZeneca (AZN) to Buy Fusion Pharmaceuticals for $2.4B
- Mar 20th, 2024 3:49 pm
These Stocks Moved the Most Today: Nvidia, AMD, Super Micro, Fusion Pharmaceuticals, Nordstrom, International Paper, Tesla, and More
- Mar 19th, 2024 8:28 pm
Fusion Rockets 99%, As Radiopharmaceuticals Space Sparks On $2 Billion AstraZeneca Takeover
- Mar 19th, 2024 8:02 pm
Stocks to Watch Tuesday: Super Micro, Fusion Pharmaceuticals, Nvidia, Unilever
- Mar 19th, 2024 6:34 pm
These Stocks Are Moving the Most Today
- Mar 19th, 2024 4:42 pm
Fusion Pharmaceuticals Stock Soars. It’s Being Acquired by AstraZeneca in $2.4 Billion Deal.
- Mar 19th, 2024 3:13 pm
Super Micro, XPeng, AstraZeneca: Trending tickers
- Mar 19th, 2024 2:46 pm
Heard on the Street: Pharma Goes Radioactive as AstraZeneca Announces Fusion Deal
- Mar 19th, 2024 2:39 pm
AstraZeneca buys Canadian cancer treatment firm for close to £2bn
- Mar 19th, 2024 11:54 am
AstraZeneca joins radiopharmaceutical deals spree with $2.4B buyout of Fusion
- Mar 19th, 2024 8:01 am
AstraZeneca bets on next-generation cancer therapy with $2 billion Fusion deal
- Mar 19th, 2024 7:10 am
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
- Mar 19th, 2024 7:00 am
Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mar 6th, 2024 12:45 pm
Fusion Pharmaceuticals to Present Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the 2024 AACR Annual Meeting
- Mar 5th, 2024 9:43 pm
Fusion (FUSN) to Report Q4 Earnings: Here's What to Expect
- Feb 26th, 2024 3:50 pm
Fusion Pharmaceuticals to Present at Upcoming March Investor Conferences
- Feb 26th, 2024 12:45 pm
These Drug Companies Are Going Nuclear to Fight Cancer
- Feb 20th, 2024 11:30 am
Scroll